Retrospective Analysis of the Experience With Larotrectinib in Patients With Solid Neoplasms With NTRK Fusion in Spain (SPAINTRK)

RecruitingOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

February 11, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions
Solid Neoplasms With NTRK Fusions
Trial Locations (14)

15706

RECRUITING

Hospital Clínico Santiago de Compostela, Santiago de Compostela

27003

RECRUITING

Hospital Universitario Lucus Augusti, Lugo

28041

RECRUITING

Hospital Universitario 12 de Octubre, Madrid

28046

RECRUITING

Hospital Universitario La Paz, Madrid

28702

RECRUITING

Hospital Universitario Infanta Sofía, San Sebastián de los Reyes

31008

RECRUITING

Hospital Universitario de Navarra, Pamplona

35016

RECRUITING

Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria

39008

RECRUITING

Hospital Universitario Marqués de Valdecilla, Santander

48903

RECRUITING

Hospital Universitario de Cruces, Barakaldo

03184

RECRUITING

Hospital Quirón Salud Torrevieja, Torrevieja

07120

COMPLETED

Hospital Universitario Son Espases, Palma

08035

RECRUITING

Hospital Universitario Vall d'Hebron, Barcelona

08036

RECRUITING

Hospital Clinic de Barcelona, Barcelona

08950

RECRUITING

Hospital San Joan de Deu, Esplugues de Llobregat

All Listed Sponsors
collaborator

MFAR

OTHER

collaborator

Grupo Español de Tumores Neuroendocrinos y Endocrinos (GETNE)

UNKNOWN

lead

Grupo Espanol de Tumores Neuroendocrinos

OTHER